Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smolen

Showing results (541-550 of 1,726) with videos related to

Pageof 173
Sort By:
Journal of Medical Economics|November 5, 2015
Febuxostat in the management of gout: a cost-effectiveness analysisLee J Smolen, James C Gahn, Ghaith Mitri, et al.
Musculoskeletal Care|March 23, 2010
Life stories of people with rheumatoid arthritis who retired early: how gender and other contextual factors shaped their everyday activities, including paid workT A Stamm, K P Machold, J Smolen, et al.
Nature Reviews. Rheumatology|January 15, 2014
Multimorbidity and rheumatic conditions-enhancing the concept of comorbidityHelga Radner, Kazuki Yoshida, Josef S Smolen, et al.
Clinical and Experimental Rheumatology|January 1, 1991
Interstitial nephritis in patients with systemic lupus erythematosus: a manifestation of concomitant Sjögren's syndrome?W B Graninger, A D Steinberg, G Meron, et al.
The Journal of Clinical Investigation|November 1, 1984
Role of phorbol diesters in in vitro murine megakaryocyte colony formationM W Long, J E Smolen, P Szczepanski, et al.
FEBS Letters|June 29, 1981
Interaction of fibronectin with C1q and its collagen-like fragment (CLF)E J Menzel, J S Smolen, L Liotta, et al.
Nature Clinical Practice. Rheumatology|August 26, 2006
Mechanisms of Disease: the link between RANKL and arthritic bone diseaseGeorg Schett, Silvia Hayer, Jochen Zwerina, et al.
Rheumatology (Oxford, England)|January 26, 2000
Recapitulation of the round-table discussion--assessing the role of anti-tumour necrosis factor therapy in the treatment of rheumatoid arthritisD E Furst, E Keystone, R N Maini, et al.
Annals of the Rheumatic Diseases|April 29, 2017
Response to: 'The time has come to revisit alternative interpretations of data underlying the EULAR management recommendations for rheumatoid arthritis' by Pirilä <i>et al</i>Josef S Smolen, Robert B M Landewé, Désirée van der Heijde
Zeitschrift Fur Immunitatsforschung. Immunobiology|September 1, 1976
Experimental pulpal immunization. I. Route of application and demonstration of immune responseC Steffen, K Keresztesi, A T Endler, et al.
Pageof 173

Showing results (541-550 of 1,726) with videos related to

Sort By:
Pageof 173
Journal of Medical Economics|November 5, 2015
Febuxostat in the management of gout: a cost-effectiveness analysisLee J Smolen, James C Gahn, Ghaith Mitri, et al.
Musculoskeletal Care|March 23, 2010
Life stories of people with rheumatoid arthritis who retired early: how gender and other contextual factors shaped their everyday activities, including paid workT A Stamm, K P Machold, J Smolen, et al.
Nature Reviews. Rheumatology|January 15, 2014
Multimorbidity and rheumatic conditions-enhancing the concept of comorbidityHelga Radner, Kazuki Yoshida, Josef S Smolen, et al.
Clinical and Experimental Rheumatology|January 1, 1991
Interstitial nephritis in patients with systemic lupus erythematosus: a manifestation of concomitant Sjögren's syndrome?W B Graninger, A D Steinberg, G Meron, et al.
The Journal of Clinical Investigation|November 1, 1984
Role of phorbol diesters in in vitro murine megakaryocyte colony formationM W Long, J E Smolen, P Szczepanski, et al.
FEBS Letters|June 29, 1981
Interaction of fibronectin with C1q and its collagen-like fragment (CLF)E J Menzel, J S Smolen, L Liotta, et al.
Nature Clinical Practice. Rheumatology|August 26, 2006
Mechanisms of Disease: the link between RANKL and arthritic bone diseaseGeorg Schett, Silvia Hayer, Jochen Zwerina, et al.
Rheumatology (Oxford, England)|January 26, 2000
Recapitulation of the round-table discussion--assessing the role of anti-tumour necrosis factor therapy in the treatment of rheumatoid arthritisD E Furst, E Keystone, R N Maini, et al.
Annals of the Rheumatic Diseases|April 29, 2017
Response to: 'The time has come to revisit alternative interpretations of data underlying the EULAR management recommendations for rheumatoid arthritis' by Pirilä <i>et al</i>Josef S Smolen, Robert B M Landewé, Désirée van der Heijde
Zeitschrift Fur Immunitatsforschung. Immunobiology|September 1, 1976
Experimental pulpal immunization. I. Route of application and demonstration of immune responseC Steffen, K Keresztesi, A T Endler, et al.
Pageof 173